Takao Suzuki

St. Luke's International University
Chuo, 1040045, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Progress and Disparities in Lung Cancer Screening in Japan: A Bayesian Analysis Toward Achieving Health Japan 21 Targets.

Progress and Disparities in Lung Cancer Screening in Japan: A Bayesian Analysis Toward Achieving Health Japan 21 Targets.

Journal: Cancers

Published: April 14, 2026

Forecasting colorectal cancer screening in Japan: regional and sex disparities threaten national targets.

Forecasting colorectal cancer screening in Japan: regional and sex disparities threaten national targets.

Journal: International journal of clinical oncology

Published: February 04, 2026

Early differentiation of Kawasaki disease preceded by cervical lymphadenopathy from bacterial cervical lymphadenitis.

Early differentiation of Kawasaki disease preceded by cervical lymphadenopathy from bacterial cervical lymphadenitis.

Journal: European journal of pediatrics

Published: October 02, 2025

Possible contribution of artificial intelligence to ophthalmologic services in rural areas.

Possible contribution of artificial intelligence to ophthalmologic services in rural areas.

Journal: Annals of agricultural and environmental medicine : AAEM

Published: September 30, 2025

Decentralized pandemic response and health equity: an analysis of socioeconomic disparities in COVID-19 mortality in Japan.

Decentralized pandemic response and health equity: an analysis of socioeconomic disparities in COVID-19 mortality in Japan.

Journal: Epidemiology and health

Published: March 01, 2025

A cross-population atlas of genetic associations for 220 human phenotypes.

A cross-population atlas of genetic associations for 220 human phenotypes.

Journal: Nature genetics

Published: October 20, 2020

Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases.

Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases.

Journal: Nature genetics

Published: February 21, 2020

KRAS mutation in patients with metastatic colorectal cancer does not preclude benefit from oxaliplatin-or irinotecan-based treatment.

KRAS mutation in patients with metastatic colorectal cancer does not preclude benefit from oxaliplatin-or irinotecan-based treatment.

Journal: Molecular and clinical oncology

Published: April 30, 2013

Remarkable regression of an osteolytic lesion of large cell lung cancer treated with zoledronic Acid: a case report.

Remarkable regression of an osteolytic lesion of large cell lung cancer treated with zoledronic Acid: a case report.

Journal: Case reports in oncology

Published: June 09, 2012

Clinical usefulness of KRAS, BRAF, and PIK3CA mutations as predictive markers of cetuximab efficacy in irinotecan- and oxaliplatin-refractory Japanese patients with metastatic colorectal cancer.

Clinical usefulness of KRAS, BRAF, and PIK3CA mutations as predictive markers of cetuximab efficacy in irinotecan- and oxaliplatin-refractory Japanese patients with metastatic colorectal cancer.

Journal: International journal of clinical oncology

Published: February 09, 2012

Safety verification trials of mFOLFIRI and sequential IRIS + bevacizumab as first- or second-line therapies for metastatic colorectal cancer in Japanese patients.

Safety verification trials of mFOLFIRI and sequential IRIS + bevacizumab as first- or second-line therapies for metastatic colorectal cancer in Japanese patients.

Journal: Oncology

Published: December 02, 2011

Showing 1-11 of 11

Last Updated: 09/26/2026